RESUMEN
Kaposi's sarcoma (KS) is an angiogenic tumor. KS lesions frequently develop in the skin and oral cavity mucosa in the head and neck regions, and pure laryngeal localization is extremely rare. We reported a 64-year-old male patient without HIV, HBV, and HCV positivity presented with a hemangiomatous lesion detected incidentally in the right vocal cord. Biopsy was taken for histopathological and immunohistochemical evaluation. Examination revealed that spindle cells were of vascular origin and expressed HHV-8, a specific marker associated with Kaposi's sarcoma-associated herpesvirus. Positron emission tomography-computed tomography (PET/CT) demonstrated an increased fluorodeoxyglucose (FDG) uptake in the vocal cord. The patient was treated with a 30 Gy volumetric arc plan. Disease-free follow-up continues in the first year after low-dose definitive RT. This is the first case report of KS in the vocal cord in which the most detailed data about RT were shared.
Asunto(s)
Herpesvirus Humano 8 , Sarcoma de Kaposi , Masculino , Humanos , Persona de Mediana Edad , Sarcoma de Kaposi/diagnóstico , Sarcoma de Kaposi/radioterapia , Pliegues Vocales , Tomografía Computarizada por Tomografía de Emisión de Positrones , Piel/patologíaRESUMEN
We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of cutaneous cancers. The indications of radiotherapy for skin cancers are not clearly defined because of the lack of randomized trials or prospective studies. For basal cell carcinomas, radiotherapy frequently offers a good local control, but a randomized trial showed that surgery is more efficient and less toxic. Indications of radiotherapy are contra-indications of surgery for patients older than 60, non-sclerodermiform histology and located in non-sensitive areas. Adjuvant radiotherapy could be proposed to squamous cell carcinomas, in case of poor prognostic factors. Dose of 60 to 70Gy are usually required, and must be modulated to the size of the lesions. Adjuvant radiotherapy seems beneficial for desmoplastic melanomas but not for the other histological types. Prophylactic nodal irradiation (45 to 50Gy), for locally advanced tumors (massive nodal involvement), decreases the locoregional failure rate but do not increase survival. Adjuvant radio- therapy (50 to 56Gy) for Merkel cell carcinomas increases also the local control rate, as demonstrated by meta-analysis and a large epidemiological study. Nodal areas must be included, if there is no surgical exploration (sentinel lymph node dissection). Kaposi sarcomas are radiosensitive and could be treated with relatively low doses (24 to 30Gy). Also, cutaneous lymphomas are good indications for radiotherapy: B lymphomas are electively treated with limited fields. The role of total skin electron therapy for T-lymphomas is still discussed; but palliative radiotherapy is very efficient in case of cutaneous nodules.
Asunto(s)
Neoplasias Cutáneas/radioterapia , Carcinoma Basocelular/radioterapia , Carcinoma Basocelular/cirugía , Carcinoma de Células de Merkel/radioterapia , Carcinoma de Células Escamosas/radioterapia , Francia , Humanos , Linfoma Cutáneo de Células T/radioterapia , Melanoma/patología , Melanoma/radioterapia , Cuidados Paliativos , Pronóstico , Oncología por Radiación , Dosificación Radioterapéutica , Radioterapia Adyuvante , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugíaRESUMEN
Kaposiform haemangioendothelioma (KHE) is a rare, primarily paediatric tumour with only a handful of case reports in the adult population. Given the paucity of evidence, this article is important in raising awareness of radiotherapy as a suitable and effective treatment in the adult population with KHE and highlights the potential limitations of topical sirolimus in these tumours.
Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Hemangioendotelioma/tratamiento farmacológico , Hemangioendotelioma/radioterapia , Inmunosupresores/uso terapéutico , Síndrome de Kasabach-Merritt/tratamiento farmacológico , Síndrome de Kasabach-Merritt/radioterapia , Sarcoma de Kaposi/tratamiento farmacológico , Sarcoma de Kaposi/radioterapia , Sirolimus/uso terapéutico , Administración Tópica , Anciano , Hemangioendotelioma/patología , Humanos , Síndrome de Kasabach-Merritt/patología , Imagen por Resonancia Magnética , Masculino , Sarcoma de Kaposi/patología , Resultado del TratamientoRESUMEN
Basal cell carcinomas and cutaneous squamous cell carcinomas are among the most common cancerous tumors in the world. Their treatment is most often based on surgery. Adjuvant radiotherapy may be indicated in case of risk factors for recurrence or as an alternative to surgery if surgery is not feasible due to the patient's advanced age and/or co-morbidities or as an alternative to potentially mutilating surgery. Radiotherapy is also part of the therapeutic arsenal for rarer skin tumors such as Merkel cell carcinoma, cutaneous lymphomas, Kaposi's disease and cutaneous adnexal carcinomas.
Asunto(s)
Carcinoma de Células de Merkel/radioterapia , Neoplasias de Anexos y Apéndices de Piel/radioterapia , Neoplasias Cutáneas/radioterapia , Carcinoma Basocelular/radioterapia , Carcinoma de Células de Merkel/patología , Carcinoma de Células Escamosas/radioterapia , Quimioradioterapia , Humanos , Linfoma/radioterapia , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/patologíaRESUMEN
BACKGROUND/AIM: We aimed to report our experience obtained by treating AIDS-related Kaposi's sarcoma (KS) with radiotherapy before the era of antiretroviral therapy. PATIENTS AND METHODS: This investigation was performed as a quality control of KS patients treated with low-dose radiotherapy at our department. KS patients referred to our section from 1983 up until 1990, were treated three times with radiotherapy (29-50 kV, 2-4 Gy), once every second week. RESULTS: Initially, 74 skin KSs were treated three times with 2 Gy, of which 70% were treated successfully. Hereafter, other 2,066 KSs on the skin were treated three times with 4 Gy with a very high success rate of 93%. Additional 165 mucous KSs were treated three times with 4 Gy, of which 91% were treated successfully. CONCLUSION: Low-dose radiotherapy is effective for the treatment of many AIDS-related KS patients.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/radioterapia , Sarcoma de Kaposi/radioterapia , Infecciones Oportunistas Relacionadas con el SIDA/patología , Adulto , Anciano , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Dosificación Radioterapéutica , Sarcoma de Kaposi/patología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/radioterapia , Neoplasias Cutáneas/virologíaRESUMEN
A novel wide-field electron arc technique with a scatterer is implemented for widespread Kaposi's sarcoma (KS) in the distal extremities. Monte Carlo beam modeling for electron arc beams was established to achieve <2% deviation from the measurements, and used for dose calculation. MC-based electron arc plan was performed using CT images of a foot and leg mimicking phantom and compared with in-vivo measurement data. We enrolled one patient with recurrent KS on the lower extremities who had been treated with photon radiation therapy. The 4- and 6-MeV electron arc plans were created, and then compared to two photon plans: two opposite photon beam and volumetric modulated arc with bolus. Compared to the two photon techniques, the electron arc plans resulted in superior dose saving to normal organs beneath the skin region, although it shows inferior coverage and homogeneity for PTV. The electron arc treatment technique with scatterer was successfully implemented for the treatment of widespread KS in the distal extremities with lower radiation exposure to the normal organs beyond the skin lesions, which could be a treatment option for recurrent skin cancer in the extremities.
Asunto(s)
Terapia de Protones/métodos , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/radioterapia , Pie , Mano , Humanos , Método de Montecarlo , Fantasmas de Imagen , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por ComputadorAsunto(s)
Enfermedades del Pie/patología , Sarcoma de Kaposi/patología , Anciano , Enfermedades del Pie/diagnóstico por imagen , Enfermedades del Pie/radioterapia , Herpesvirus Humano 8 , Humanos , Ganglios Linfáticos/patología , Masculino , Sarcoma de Kaposi/diagnóstico por imagen , Sarcoma de Kaposi/radioterapia , Sarcoma de Kaposi/virología , Tomografía Computarizada por Rayos XRESUMEN
Kaposi's sarcoma (KS) is an uncommon neoplastic vascular disease. The standard treatment for localized classic KS lesions is surgical excision or radiation. Superficial skin lesions are generally treated with electrons or low-energy photon fields using boluses. Radiotherapy (RT) can be used for poor surgical candidates or when surgery is expected to result in a poor cosmetic or functional outcome. This study is the first to describe a case of KS of the toe and web treated with electron RT, which precisely targeted the irregular skin lesion with a markedly higher presided effective treatment. An electron field is often limited in its effectiveness to deliver a homogeneous dose in cases with irregular contours. Here, we report our successful experience using low-energy electron beam radiation to treat KS of the toe and web. The patient was a 78-year-old woman who was diagnosed with KS located on the first and second toe and web, based on radiology, pathology, and immunohistochemical examinations. KS was located on the left foot and measured more than 2.5 cm. No regional nodal or distant organ metastasis was observed. She was medically inoperable. RT was performed using a 6-MeV electron with a 0.5-cm bolus and a dose of 50 Gy delivered in 25 fractions. Follow-up computed tomography 2 months after RT revealed a complete tumor response. Toxicity was limited to mild skin desquamation during treatment. The patient remains alive and has shown no evidence of disease for 2 years. This study suggests that electron RT is a safe and effective treatment option for skin lesions located on the toe and web.
Asunto(s)
Electrones/uso terapéutico , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/radioterapia , Dedos del Pie/efectos de la radiación , Anciano , Femenino , Humanos , Inducción de Remisión , Sarcoma de Kaposi/patología , Neoplasias Cutáneas/patología , Dedos del Pie/patología , Resultado del TratamientoRESUMEN
BACKGROUND AND OBJECTIVES: Classic Kaposi's sarcoma (KS) is a multifocal angioproliferative disorder with a long and indolent course typically affecting the lower extremities of elderly men. Multiple nodules with a rapid growth may sometimes develop, causing pain, bleeding, and discomfort on walking. In such cases, immediate intervention using different methods, including laser therapy, is advisable. We report our experience in classic KS patients with the use of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser delivered through a tilted angle. STUDY DESIGN/MATERIALS AND METHODS: A total of 81 KS nodules (0.5-3 cm size) located in the feet or lower limbs of nine patients (mean age: 78.8 years; age range: 64-86 years) were selected for treatment with Nd:YAG laser (5-7 mm spot, 140-200 J/cm2 fluence, 5 ms triple pulse with 10 ms delay). The laser beam was delivered at the periphery of each nodule using a tilted angle of 30° to 60° according to lesion size in order to better target the feeding vessels located in the inner and basal depth of the lesion and minimize tissue damage. The treatment outcome was evaluated by clinical photograph, videodermatoscopy, and ultrasound scanning performed before and after treatment, and at each monthly follow-up visit. RESULTS: All treated patients showed full recovery, with negligible scarring, no residual hyperpigmentation, and complete regression of pain. Treatment discomfort was minimal and use of topical anesthetics was not needed. No recurrences were observed at 12-month follow up. CONCLUSIONS: Long-pulse Nd:YAG laser delivered using a tilted angle is a fast, easy, effective, comfortable, and safe treatment option available to promptly shrink bulky, painful, or bleeding nodules with minimal discomfort and gives excellent functional and cosmetic results. Lasers Surg. Med. © 2020 Wiley Periodicals, Inc.
Asunto(s)
Terapia por Láser , Láseres de Estado Sólido , Sarcoma de Kaposi , Anciano , Anciano de 80 o más Años , Estudios de Seguimiento , Humanos , Láseres de Estado Sólido/uso terapéutico , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Sarcoma de Kaposi/radioterapia , Resultado del TratamientoRESUMEN
Head and neck involvement of Kaposi's sarcoma is rarely encountered, especially for the Mediterranean classic subtype. Here we report a case of non-AIDS related laryngeal Kaposi's sarcoma in a 77-year-old Tunisian man complaining of 4-month history of hoarseness and dysphagia. The patient underwent exclusive local radiotherapy with a prescription dose of 45 Gy delivered in 1.8 Gy daily fractions. He remained complaint-free for 3 months.
Asunto(s)
Neoplasias Laríngeas/diagnóstico , Sarcoma de Kaposi/diagnóstico , Anciano , Trastornos de Deglución/etiología , Ronquera/etiología , Humanos , Neoplasias Laríngeas/patología , Neoplasias Laríngeas/radioterapia , Masculino , Sarcoma de Kaposi/patología , Sarcoma de Kaposi/radioterapiaAsunto(s)
Recurrencia Local de Neoplasia/radioterapia , Síndrome Pospoliomielitis/complicaciones , Sarcoma de Kaposi/complicaciones , Neoplasias Cutáneas/complicaciones , Anciano , Biopsia , Humanos , Masculino , Sarcoma de Kaposi/patología , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/radioterapiaAsunto(s)
Recurrencia Local de Neoplasia/diagnóstico , Paniculitis/diagnóstico , Radiodermatitis/diagnóstico , Sarcoma de Kaposi/radioterapia , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Paniculitis/etiología , Paniculitis/patología , Radiodermatitis/etiología , Radiodermatitis/patología , Piel/patología , Piel/efectos de la radiaciónRESUMEN
B-cell chronic lymphocytic leukemia (CLL), a low-grade malignancy consisting of CD5(+), CD23(+), and CD43(+) small B lymphocytes, is the most frequent leukemia in the western world. Patients with CLL may exhibit skin changes characterized by histopathologic evidence of infiltration by atypical B lymphocytes, also known as "specific cutaneous infiltrates of CLL"; in addition, CLL is known to be associated with an increased risk of second cancers, including Kaposi sarcoma (KS). The combination of KS and CLL within the same cutaneous biopsy specimen has only rarely been described. We report a peculiar case of KS occurring in a patient with CLL, in which histopathological evaluation of KS lesions revealed prominent accumulation of CLL lymphocytes within neoplastic vascular spaces. We believe that our findings represent a novel example of intravascular colonization of vascular neoplasms by neoplastic lymphoid cells, further expanding the evergrowing spectrum of specific cutaneous infiltrates of CLL.
Asunto(s)
Leucemia Linfocítica Crónica de Células B/patología , Infiltración Leucémica/patología , Neoplasias Primarias Secundarias/patología , Sarcoma de Kaposi/patología , Neoplasias Cutáneas/patología , Anciano , Biomarcadores de Tumor/análisis , Humanos , Leucemia Linfocítica Crónica de Células B/metabolismo , Infiltración Leucémica/metabolismo , Infiltración Leucémica/radioterapia , Masculino , Neoplasias Primarias Secundarias/química , Sarcoma de Kaposi/química , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/química , Neoplasias Cutáneas/radioterapiaAsunto(s)
Infecciones por VIH/diagnóstico , Sarcoma de Kaposi/diagnóstico , Adulto , Antibióticos Antineoplásicos/uso terapéutico , Terapia Antirretroviral Altamente Activa , Bisexualidad , Doxorrubicina/análogos & derivados , Doxorrubicina/uso terapéutico , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Humanos , Masculino , Polietilenglicoles/uso terapéutico , Radioterapia , Sarcoma de Kaposi/complicaciones , Sarcoma de Kaposi/tratamiento farmacológico , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/tratamiento farmacológico , Resultado del TratamientoRESUMEN
BACKGROUND: Kaposi's sarcoma (KS) is a rare tumor that affects mainly immunodeficient and elderly patients. AIM: To describe the features and outcomes of a cohort of patients with different types of KS treated locally with radiotherapy (RT). PATIENTS AND METHODS: Retrospective review of patients with KS referred to our radiation oncology center for local treatment of symptomatic lesions that did not respond to high activity anti-retroviral therapy or chemotherapy. RESULTS: Between January 1995 and December 2016, 20 patients with a median age of 40 years (18 males) with KS were assessed and treated with RT due to symptomatic lesions. The most common KS type was epidemic in 15 patients, followed by the classic type in three and the iatrogenic variety in two. In patients with non-epidemic varieties, SK was exclusively cutaneous, while visceral involvement was present in 46% of patients with epidemic SK. Complete response was observed in 95% of cases. Skin toxicity caused by RT was mild in all cases. CONCLUSIONS: RT may be considered as a reasonable local treatment choice in classic, iatrogenic and epidemic varieties of KS.
Asunto(s)
Fraccionamiento de la Dosis de Radiación , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/radioterapia , Adulto , Estudios de Cohortes , Femenino , Humanos , Masculino , Inducción de Remisión , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Kaposi sarcoma is a rare adult neoplasm and there has been no certain consensus on standard treatment, either local or systemic. Radiotherapy is an effective, suitable treatment modality. Between 1996 and 2016, patients who were diagnosed with Kaposi sarcoma and referred to our clinic for radiotherapy were included in this retrospective study. Ninety-two patients were examined in total and it was diagnosed that all the patients had non-HIV associated Kaposi's sarcoma. There were 36 (39%) females and 56 (61%) males and female to male ratio was 2/3. Median age at presentation was 72 (30-93) years. Sixty-eight patients (77%) were treated with 8 Gy (1 fraction), 15 patients (16%) were treated with 20 Gy (2 Gy/fraction), four patients (4%) were treated 25 Gy (2.5 Gy/fraction), and five patients (6%) were treated 30 Gy (3 Gy/fraction). The median follow-up time was 72 (5-192) months. The complete response at 5 years was 91.6% with >20 Gy and 89.6% with 8 Gy. Radiotherapy is an effective, suitable treatment modality of Classic Kaposi sarcoma and usually, radiotherapy is well tolerated with minimal side effects.
Asunto(s)
Fraccionamiento de la Dosis de Radiación , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/radioterapia , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Radioterapia/efectos adversos , Inducción de Remisión , Estudios Retrospectivos , Sarcoma de Kaposi/secundario , Neoplasias Cutáneas/patología , Factores de Tiempo , Resultado del Tratamiento , TurquíaRESUMEN
Kaposi's sarcoma (KS) is a systemic neoplastic disease that can present cutaneous symptoms and is usually treated with a systematic approach due to its extent. Due to its radiosensitivity, radiotherapy is considered one of its main treatments, for palliation and local control of the skin and mucosal lesions. The aim of this paper was to report the first case of KS treated by hemi-body electron irradiation protocol in Greece. A fractionated 40 Gy hemi-body electron irradiation was prescribed to a 60-year-old male patient with KS at his legs. Dose uniformity was verified on a daily basis by thermoluminescence dosimetry (TLD). The treatment resulted to complete clinical response. Limited irradiation-derived side effects appeared. This is the first case ever to be treated with hemi-body electron irradiation protocol in Greece. To the best of our knowledge, this is also the first time that a single field hemi-body electron beam irradiation at a total skin electron beam (TSEB)-like configuration is reported to be used for KS.
Asunto(s)
Sarcoma de Kaposi/radioterapia , Tomografía Computarizada por Rayos X/métodos , Humanos , Extremidad Inferior/patología , Extremidad Inferior/efectos de la radiación , Masculino , Persona de Mediana Edad , Sarcoma de Kaposi/patología , Tomografía Computarizada por Rayos X/instrumentaciónRESUMEN
Background: Kaposi's sarcoma (KS) is a rare tumor that affects mainly immunodeficient and elderly patients. Aim: To describe the features and outcomes of a cohort of patients with different types of KS treated locally with radiotherapy (RT). Patients and Methods: Retrospective review of patients with KS referred to our radiation oncology center for local treatment of symptomatic lesions that did not respond to high activity anti-retroviral therapy or chemotherapy. Results: Between January 1995 and December 2016, 20 patients with a median age of 40 years (18 males) with KS were assessed and treated with RT due to symptomatic lesions. The most common KS type was epidemic in 15 patients, followed by the classic type in three and the iatrogenic variety in two. In patients with non-epidemic varieties, SK was exclusively cutaneous, while visceral involvement was present in 46% of patients with epidemic SK. Complete response was observed in 95% of cases. Skin toxicity caused by RT was mild in all cases. Conclusions: RT may be considered as a reasonable local treatment choice in classic, iatrogenic and epidemic varieties of KS.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Sarcoma de Kaposi/radioterapia , Neoplasias Cutáneas/radioterapia , Fraccionamiento de la Dosis de Radiación , Inducción de Remisión , Estudios Retrospectivos , Estudios de Cohortes , Resultado del TratamientoRESUMEN
BACKGROUND: Classic Kaposi's sarcoma is a lymphatic endothelial cell neoplasm usually present on the skin of the upper and lower extremities. Although it commonly affects human immunodeficiency virus positive patients, there have been some human immunodeficiency virus negative cases reported. We report an uncommon presentation of stage IV classic Kaposi's sarcoma in an human immunodeficiency virus negative patient in Latin America with complete clinical response using only radiation therapy treatment. CASE PRESENTATION: A 78-year-old Mexican man with no evidence of human immunodeficiency virus infection presented with a painful widespread dermatosis with maculopapular, nodular, violaceous lesions on his legs and ulcerated lesions on his feet. A biopsy confirmed the lesions as classic Kaposi's sarcoma. Radiotherapy treatment was delivered, prescribing a total dose of 30 Gy in 15 fractions with a complete clinical response within 15 months of follow-up. CONCLUSIONS: This is an unusual case since it is uncommon to use radiation therapy as the single treatment in stage IV classic Kaposi's sarcoma; the efficacy of the treatment is shown in the impact in our patient's recurrence-free survival, local control, and palliation of our patient's symptoms.